bbt-877
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 13, 2019 (NCT03830125)
Timeline
Indications
Mechanism of action
- AutotaxinINHIBITOR
ENPP2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05483907 | Phase 2 | Nov 10, 2022 | Bridge Biotherapeutics, Inc. |
| NCT04138849 | Phase 1 | Oct 1, 2019 | Bridge Biotherapeutics, Inc., KCRN Research |
| NCT04138836 | Phase 1 | Sep 17, 2019 | Bridge Biotherapeutics, Inc., KCRN Research |
| NCT03830125 | Phase 1 | Feb 13, 2019 | Bridge Biotherapeutics, Inc., KCRN Research |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bridge Biotherapeutics, Inc. | For profit | 4 | 4 | 2 | 2019 |
| KCRN Research | For profit | 3 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1